fructose-1,6-diphosphate Cas:488-69-7

We are fructose-1,6-diphosphate CAS:488-69-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

fructose-1,6-diphosphate cas 488-69-7 manufacturer supply

Chemical Name: Fructose-1,6-diphosphate

CAS No.:488-69-7

Molecular Formula: C6H14O12P2

Molecular Weight: 340.115682

Appearance: White crystalline or crystalline powder

Assay: 98%min

Category: Pharmaceutical Intermediates

• Description

Description

CAS 488-69-7

Chemical Name: Fructose-1,6-diphosphate

CAS No.:488-69-7

Molecular Formula: C6H14O12P2

Chemical Structure:

Molecular weight: 340.115682

Appearance: White crystalline or crystalline powder

Assay: 98%min

CAS 488-69-7 Typical Properties

Item	Specifications	Results
Appearance	White crystalline or crystalline powder	White crystalline
Identify
TLC	Must be similar in TLC spots and colour	Conforms
Precipitation	positive reaction	positive reaction
Sodium salt	positive reaction	positive reaction
IR	Must be similarto parallel table	Conforms
Inspect
Granularity	30	Conforms
Acidity	PH: 5.5～6.5	6.01
Appearance of solution	colorless	Conforms
Moisture	24.0～27.0％	26.59%
Heavy metal（Pb），mg/kg	≤1.5	Conforms
Arsenic（As），mg/kg	≤1.0	Conforms
Bacterial count，cfu/g	≤1000	Conforms
Colibacillus，MPN/100g	≤40	Conforms
Yeast, mold，cfu/g	≤25	Conforms
Assay, Anhydrous，%	≥98.0％	98.92％

What isFructose-1,6-diphosphate？

Fructose-1,6-diphosphate is a sugar metabolism intermediate existing in the human body. It regulates the activity of several enzymes in glucose metabolism, increases the concentration of intracellular adenosine triphosphate and phosphocreatine, promotes potassium influx, and increases intracellular red blood cells. The content of phosphoglycerate inhibits the release of oxygen free radicals and histamine, alleviates the tissue damage caused by ischemia and hypoxia, and has a good protective effect on the myocardium under ischemia. It is often used for myocardial ischemia and heart. Adjuvant therapy for failure. The side effects are mainly pain at the injection site, numbness of the lips, occasional dizziness, chest tightness and allergic reactions. In this patient, a severe allergic reaction occurred 1 minute after the drug administration, suggesting that clinicians should closely observe the changes of the patient’s condition when using sodium fructose diphosphate. Once an adverse reaction occurs, the drug should be discontinued immediately and the corresponding treatment should be given in time. In addition, the drug should be used with caution for allergic persons.

CAS 488-69-7 Usage

1. This product belongs to the cardiovascular system.

2. Fructose sodium diphosphate for injection, the indication for this product is suitable for hypophosphatemia. Hypophosphatemia can occur in acute conditions, such as blood transfusions, surgery under extracorporeal circulation, parenteral nutrition, and in the depletion of carbonic acid in chronic conditions such as chronic alcoholism, chronic malnutrition, and chronic respiratory failure. Seal and store in a cool place (not more than 20 ° C).

CAS 488-69-7 Packaging and Shipping

25kg per drum

CAS 488-69-7 Storage

Keep in a well closed,light-resistant, dry and cool place.

Related Products:1,1,2,2-Tetrafluoro-4-[3,3,4,4-tetrafluoro-4-(1,2,2,2-tetrafluoro-1-trifluoromethyl-ethoxy)-butyldisulfanyl]-1-(1,2,2,2-tetrafluoro-1-trifluoromethyl-ethoxy)-butane manufacturer | 2-iodo-4-phenoxyphenol supplier | VUF14172 producer.